Abstract
In this chapter we explain:
-
How kidney disease affects children’s growth and development
-
How kidney care is transferred through adolescence
-
The role of obesity in kidney disease
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tönshoff B, Kiepe D, Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol. 2005;20(3):279. http://link.springer.com/article/10.1007%2Fs00467-005-1821-0.
Stonebrook E, Mahan JD. Treatment of growth retardation in a child with CKD. Clin J Am Soc Nephrol. 2019;14(11):1658–60. https://doi.org/10.2215/CJN.03960319. pii: CJN.03960319. https://cjasn.asnjournals.org/content/early/2019/07/25/CJN.03960319.
Drube J, Wan M, Bonthuis M, Wühl E, Bacchetta J, Santos F, Grenda R, Edefonti A, Harambat J, Shroff R, Tönshoff B, Haffner D, European Society for Paediatric Nephrology Chronic Kidney Disease Mineral and Bone Disorders, Dialysis, and Transplantation Working Groups. Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol. 2019;15(9):577–89. https://doi.org/10.1038/s41581-019-0161-4. Epub 2019 Jun 13. https://www.nature.com/articles/s41581-019-0161-4.
Abdel-Hafez M, Shimada M, Lee PY, Johnson RJ, Garin EH. Idiopathic nephrotic syndrome and atopy: is there a common link? Am J Kidney Dis. 2009;54(5):945–53. https://doi.org/10.1053/j.ajkd.2009.03.019. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895907.
Calderon-Margalit R, Golan E, Twig G, Leiba A, Tzur D, Afek A, Skorecki K, Vivante A. History of childhood kidney disease and risk of adult end-stage renal disease. N Engl J Med. 2018;378(5):428–38. https://doi.org/10.1056/NEJMoa1700993. https://www.nejm.org/doi/10.1056/NEJMoa1700993?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov.
Watson AR, Warady BA. Transition from pediatric to adult-centered care. Dial Transplant. 2011;40(4):156–8. http://onlinelibrary.wiley.com/enhanced/doi/10.1002/dat.20557/.
Mallamaci F, Tripepi G. Obesity and CKD progression: hard facts on fat CKD patients. Nephrol Dial Transplant. 2013;28(Suppl 4):iv105–8. https://doi.org/10.1093/ndt/gft391. http://ndt.oxfordjournals.org/content/28/suppl_4/iv105.full.pdf.
Herrington WG, Smith M, Bankhead C, Matsushita K, Stevens S, Holt T, Hobbs FD, Coresh J, Woodward M. Body-mass index and risk of advanced chronic kidney disease: prospective analyses from a primary care cohort of 1.4 million adults in England. PLoS One. 2017;12(3):e0173515. https://doi.org/10.1371/journal.pone.0173515. http://dx.plos.org/10.1371/journal.pone.0173515.
Stefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population. Kidney Int. 2018;93(5):1183–90. https://doi.org/10.1016/j.kint.2017.11.012. Epub 2018 Feb 1. https://www.kidney-international.org/article/S0085-2538(17)30828-1/fulltext.
The Look AHEAD Research Group. Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801–9. http://www.thelancet.com/journals/landia/article/PIIS2213-8587(14)70156-1/abstract.
Friedman AN, Wahed AS, Wang J, Courcoulas AP, Dakin G, Hinojosa MW, Kimmel PL, Mitchell JE, Pomp A, Pories WJ, Purnell JQ, le Roux C, Spaniolas K, Steffen KJ, Thirlby R, Wolfe B. Effect of bariatric surgery on CKD risk. J Am Soc Nephrol. 2018;29(4):1289–300. https://doi.org/10.1681/ASN.2017060707. https://jasn.asnjournals.org/content/29/4/1289.long.
Chang AR, Chen Y, Still C, Wood GC, Kirchner HL, Lewis M, Kramer H, Hartle JE, Carey D, Appel LJ, Grams ME. Bariatric surgery is associated with improvement in kidney outcomes. Kidney Int. 2016;90(1):164–71. https://doi.org/10.1016/j.kint.2016.02.039. Epub 2016 May 12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912457.
Pifer TB, Mccullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ, Young EW. Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int. 2002;62:2238–45. https://doi.org/10.1046/j.1523-1755.2002.00658.x. http://www.nature.com/ki/journal/v62/n6/full/4493347a.html.
Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, Marcelli D, Schernthaner G, Eckardt KU, Floege J, Froissart M, Anker SD, ARO Steering Committee. Inflammation modifies the paradoxical association between body mass index and mortality in hemodialysis patients. J Am Soc Nephrol. 2016;27(5):1479–86. https://doi.org/10.1681/ASN.2015030252. Epub 2015 Nov 13. http://jasn.asnjournals.org/cgi/pmidlookup?view=long&pmid=26567245.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rayner, H.C., Thomas, M.E., Milford, D.V. (2020). Height and Weight: The Effects of Kidney Disease on Development; Links Between Obesity and Kidney Disease. In: Understanding Kidney Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-43027-6_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-43027-6_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-43026-9
Online ISBN: 978-3-030-43027-6
eBook Packages: MedicineMedicine (R0)